Portfolio company
Biolipox AB
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This pharmaceutical company develops treatments for respiratory and inflammatory diseases including asthma and arthritis for patients and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Resistentia Pharmaceuticals AB
This company develops immunotherapeutic products for patients suffering from allergic asthma and inflammatory disorders.
Aiolos Bio
This biopharmaceutical company develops monoclonal antibody therapies for patients suffering from respiratory and inflammatory conditions such as moderate-to-severe asthma.
Oxagen
This biopharmaceutical company develops small molecule drugs for inflammatory and respiratory diseases, primarily targeting healthcare providers and pharmaceutical partners for clinical research.
RSPR Pharma AB
The company develops oral therapies for respiratory and cardiovascular diseases, targeting patients with uncontrolled asthma and rare conditions.
LTB4 Sweden AB
The company develops leukotriene B4 based therapies to treat inflammatory conditions and infectious diseases, such as HIV, for patients with unmet medical needs.
Areteia Therapeutics
The company develops an oral medication for patients with eosinophilic asthma to reduce inflammation and manage their condition.
BioCrine AB
This company develops diabetes treatments and in-vivo imaging technology for pharmaceutical and biotechnology partners and academic researchers.
Apollo Therapeutics
This biopharmaceutical company develops new medicines based on medical research for patients with various therapeutic needs.